NCT06370780 Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically
| NCT ID | NCT06370780 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Los Angeles |
| Condition | HIV Infections |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-02-09 |
| Primary Completion | 2028-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2024-02-09 with a primary completion date of 2028-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in rural areas. Investigators will examine the syndemics underlying these outcomes including substance use, mental health, and barriers to HIV care including racial discrimination, stigma and rural isolation.
Eligibility Criteria
Inclusion Criteria: * Have access to a personal smartphone device; * Over 18 years of age; * Speak English or Spanish; * Living with HIV * Are either 1) not currently virally suppressed, 2) not currently engaged in care, or 3) have one or more factors associated with viral non suppression including a history of missed appointments or viral non suppression; * Active substance use or mental health disorder; * Willing and able to provide written informed consent to take part in the study. Exclusion Criteria: * Unwilling or unable to provide reliable contact information; * Unwilling to provide blood sample for HIV virology testing; * Living with HIV and virally suppressed and not at risk of becoming unsuppressed in the near future.
Contact & Investigator
Pamina Gorbach, DrPh
PRINCIPAL INVESTIGATOR
University of California, Los Angeles
Frequently Asked Questions
Who can join the NCT06370780 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06370780 currently recruiting?
Yes, NCT06370780 is actively recruiting participants. Contact the research team at RemainApp@ph.ucla.edu for enrollment information.
Where is the NCT06370780 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT06370780 clinical trial?
NCT06370780 is sponsored by University of California, Los Angeles. The principal investigator is Pamina Gorbach, DrPh at University of California, Los Angeles. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.